FDA ap­proves Nar­can opi­oid over­dose re­ver­sal spray for over-the-counter sale

The FDA to­day ap­proved Emer­gent BioSo­lu­tions’ Nar­can brand nalox­one nasal spray for over-the-counter sales. The nod was ex­pect­ed and comes on the heels of a unan­i­mous 19-0 ad­vi­so­ry com­mit­tee vote in fa­vor of ap­proval last month.

The move to OTC means the opi­oid over­dose re­ver­sal agent will now be avail­able on gro­cery, con­ve­nience and gas sta­tions shelves, as well as po­ten­tial­ly for pur­chase on­line.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters